_version_ 1782407621577277440
author Janku, Filip
Angenendt, Philipp
Tsimberidou, Apostolia M.
Fu, Siqing
Naing, Aung
Falchook, Gerald S.
Hong, David S.
Holley, Veronica R.
Cabrilo, Goran
Wheler, Jennifer J.
Piha-Paul, Sarina A.
Zinner, Ralph G.
Bedikian, Agop Y.
Overman, Michael J.
Kee, Bryan K.
Kim, Kevin B.
Kopetz, E. Scott
Luthra, Rajyalakshmi
Diehl, Frank
Meric-Bernstam, Funda
Kurzrock, Razelle
author_facet Janku, Filip
Angenendt, Philipp
Tsimberidou, Apostolia M.
Fu, Siqing
Naing, Aung
Falchook, Gerald S.
Hong, David S.
Holley, Veronica R.
Cabrilo, Goran
Wheler, Jennifer J.
Piha-Paul, Sarina A.
Zinner, Ralph G.
Bedikian, Agop Y.
Overman, Michael J.
Kee, Bryan K.
Kim, Kevin B.
Kopetz, E. Scott
Luthra, Rajyalakshmi
Diehl, Frank
Meric-Bernstam, Funda
Kurzrock, Razelle
author_sort Janku, Filip
collection PubMed
description
format Online
Article
Text
id pubmed-4695208
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-46952082016-01-26 Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies Janku, Filip Angenendt, Philipp Tsimberidou, Apostolia M. Fu, Siqing Naing, Aung Falchook, Gerald S. Hong, David S. Holley, Veronica R. Cabrilo, Goran Wheler, Jennifer J. Piha-Paul, Sarina A. Zinner, Ralph G. Bedikian, Agop Y. Overman, Michael J. Kee, Bryan K. Kim, Kevin B. Kopetz, E. Scott Luthra, Rajyalakshmi Diehl, Frank Meric-Bernstam, Funda Kurzrock, Razelle Oncotarget Errata Impact Journals LLC 2015-09-14 /pmc/articles/PMC4695208/ /pubmed/26405159 Text en Copyright: © 2015 Janku et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Errata
Janku, Filip
Angenendt, Philipp
Tsimberidou, Apostolia M.
Fu, Siqing
Naing, Aung
Falchook, Gerald S.
Hong, David S.
Holley, Veronica R.
Cabrilo, Goran
Wheler, Jennifer J.
Piha-Paul, Sarina A.
Zinner, Ralph G.
Bedikian, Agop Y.
Overman, Michael J.
Kee, Bryan K.
Kim, Kevin B.
Kopetz, E. Scott
Luthra, Rajyalakshmi
Diehl, Frank
Meric-Bernstam, Funda
Kurzrock, Razelle
Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
title Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
title_full Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
title_fullStr Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
title_full_unstemmed Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
title_short Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
title_sort erratum: actionable mutations in plasma cell-free dna in patients with advanced cancers referred for experimental targeted therapies
topic Errata
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695208/
https://www.ncbi.nlm.nih.gov/pubmed/26405159
work_keys_str_mv AT jankufilip erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT angenendtphilipp erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT tsimberidouapostoliam erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT fusiqing erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT naingaung erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT falchookgeralds erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT hongdavids erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT holleyveronicar erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT cabrilogoran erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT whelerjenniferj erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT pihapaulsarinaa erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT zinnerralphg erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT bedikianagopy erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT overmanmichaelj erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT keebryank erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT kimkevinb erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT kopetzescott erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT luthrarajyalakshmi erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT diehlfrank erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT mericbernstamfunda erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies
AT kurzrockrazelle erratumactionablemutationsinplasmacellfreednainpatientswithadvancedcancersreferredforexperimentaltargetedtherapies